Your source for breaking news, topical videos, and slides covering cardiovascular disease and interventions. Register at tctmd.com
Joined May 2009
- Tweets 20,540
- Following 6,675
- Followers 28,060
- Likes 7,214
7,879 Photos and videos
For PCI patients, prasugrel stands out as the best oral P2Y12 inhibitor, associated with a lower likelihood of MACE, MI, and stent thrombosis without an increase in major bleeding, based on a new meta-analysis. tctmd.com/news/meta-analysis…
2
4
661
A multidisciplinary survey of physicians performing endovascular revascularization shows support for a large-scale RCT to evaluate the clinical value of intravascular ultrasound guidance in patients with chronic limb-threatening ischemia (CLTI). tctmd.com/news/ivus-use-clti…
1
1
443
TCTMD retweeted
We’re celebrating sports, style, and groundbreaking science at #NYValves2026. Show your spirit and join the fun!💥✨
⚽ Day One: Jersey Day — Rep your favorite team and bring the energy.
👟 Day Two: White Sneaker Day — Lace up your best kicks and step into innovation in style.
Plan your experience at the premier summit in structural heart care with the Program Guide! 👉 ow.ly/uAby50Zb8fX
#CardioX #CardioTwitter #CardioEd #CardioResearch @Kalazizimd @bapat_savrtavr @BurkhoffMD @djc795 @npfam1 @igeorge1975 @jgranadacrf @AdamGreenbaumMD @hahn_rt @EdwinHoMD @TsuyoshiKaneko1 @SusheelKodaliMD @azeemlatib @MartyBLeon @TheDoctorMack @MVMadhavanMD @jamiemccabeMD @modine_thomas @tnazifMD @PopmaJeffrey @laurenranard @MarwanSaadMD @psorajja @GilbertTangMD @drnvanmieghem @vonBardelebenRS @PradeepYadavMD @mirvatalasnag @triciarawh @TCTConference @TCTMD @sbhci @Dr_ibrahimHarbi @CathWhisperer @caldera_99 @aelsab @mderdem3 @CAESmedmd @NadeenFaza @RaghavG_MD @evandrofilhobr @GiorgioMedranda @purviparwani @SaadUrRahman55 @LucySafi @ShariqShamimMD @Sticchi_Alex @ladyheart_md
7
13
1,187
In patients with atrial fibrillation taking a direct oral anticoagulant (DOAC), COX-2-selective nonsteroidal anti-inflammatory drugs (NSAIDs) appear to be safer than their nonselective counterparts, based on observational data. tctmd.com/news/cox-2-selecti…
1
345
On this new episode of Hearts & Minds, complex PCI expert Margaret McEntegart (@mbmcentegart) speaks with @TCTMD_Yael about how personal challenges have shaped her professional choices, her achievement of a major career milestone, and more. tctmd.com/audio/6-margaret-m…
2
3
399
Heat-related CVD burden in the US is projected to rise by 2050, leaving older patients particularly vulnerable—especially in the Pacific Northwest and the Southern and Midwestern states—as greenhouse gas emissions continue to increase. tctmd.com/news/heat-related-…
2
1
441
Taking a GLP-1 drug benefits patients with type 2 diabetes and chronic kidney disease, regardless of CVD status, by preventing kidney events and reducing mortality. More on the FLOW trial analysis here: tctmd.com/news/semaglutide-b…
2
318
Watch experts discuss the late-breaking results from the CHAMPION-AF trial, which compares the WATCHMAN FLX LAAC device with NOACs as a first-line option for patients with nonvalvular atrial fibrillation. tctmd.com/CHAMPION-AF-Interp…
3
3
639
Early results show promise for the use of a single infusion gene-editing therapy called VERVE-102 to lower LDL cholesterol in patients with heterozygous familial hypercholesterolemia (FH) and/or premature coronary disease, according to an analysis of the phase I Heart-2 study. tctmd.com/news/gene-editing-…
1
1
437
As part of an annual tradition at CRF’s Fellows Course, TCTMD’s @TCTMD_Yael asked trainees where they hope to see themselves in five years. tctmd.com/videos/looking-ahe…
#Fellows2026
1
3
1,257
More than three years later, results for the ANTHEM-HFrEF trial of vagal nerve stimulation have been released. The study was initially halted by sponsor LivaNova despite the data and safety monitoring board (DSMB) urging its continuation. tctmd.com/news/anthem-hfref-…
3
691